A Hong Kong man has developed the world's first ever human case of the rat version of the hepatitis E virus, according to new research from one of the city's leading universities.
Sep 28, 2018
7
1246
A virus that causes childhood coughs and colds could help in the fight against primary liver cancer, according to a study.
Nov 16, 2016
1
7795
(Medical Xpress) -- A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team ...
Feb 16, 2012
0
0
A group of Brazilian scientists has achieved promising results using isolated compounds from the venom of the South American rattlesnake to combat hepatitis C. The investigation was based on records in scientific literature ...
Feb 9, 2018
0
800
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that ...
Nov 24, 2021
0
5
Most people react very well to vaccinations and have an adequate immune response against the pathogens. The lack of response to vaccines, so-called vaccine failure, affects between one and ten percent of people. The reasons ...
Aug 15, 2013
0
3
(Medical Xpress) -- A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report.
Jan 5, 2012
0
0
In a study of an all-oral drug regimen, a majority of volunteers with liver damage due to hepatitis C virus (HCV) infection were cured following a six-month course of therapy that combined an experimental drug, sofosbuvir, ...
Aug 27, 2013
0
0
The hepatitis C virus hijacks the body's immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore immune function, allowing ...
Sep 3, 2013
0
0
The CUNY School of Medicine at The City College of New York and TechnoVax, Inc., a biotechnology developer of novel vaccines, announce a breakthrough in their collaborative effort to develop a vaccine for COVID-19. Scientists ...
Aug 19, 2020
0
79
